The FDA accepted an NDA for a bictegravir and lenacapavir single-tablet regimen for adults with HIV-1 who have achieved virologic suppression.

Abstract: Testing of spin-based quantum devices is currently performed through quantum dot and qubit measurements at deep cryogenic temperatures, well below 1 K. At such low temperatures, the testing ...

Learning health systems turn data into action — rapidly, safely, and continuously — so that innovation truly improves care.

Reimagining clinical trial engagement through community partnership, pragmatic design, and artificial intelligence–enabled ...